Ezetimibe itself cannot cross the blood-brain barrier, but its metabolite ezetimibe glucuronide can penetrate in small amounts and has shown anti-inflammatory effects in the brain in animal studies.
Snapshot · The Peter Attia Drive
Ezetimibe itself cannot cross the blood-brain barrier, but its metabolite ezetimibe glucuronide can penetrate in small amounts and has shown anti-inflammatory effects in the brain in animal studies.
Where this was said
At 1:20:38 · chapter starts 1:19:30
Peter asks about ezetimibe — a drug that works in the gut by blocking intestinal cholesterol absorption and might seem irrelevant to brain health. Tom acknowledges it shouldn't have a brain effect based on first principles, but then reveals that ezetimibe's main metabolite, ezetimibe glucuronide, can cross the blood-brain barrier in small amounts [1] — Tom Dayspring "Ezetimibe works in the gut and can't cross the blood-brain barrier — but its metabolite, ezetimibe glucuronide, can. Animal studies show it…" 1:19:40 . In animal studies, it interferes with hexokinase and reduces glycosylation of brain proteins, producing anti-inflammatory effects. Neurologists who specialize in Alzheimer's prevention — Tom names Richard Isaacson and Kelly Endiotes — have anecdotally observed cognitive benefits in patients taking ezetimibe, beyond what would be expected from ApoB lowering alone. Tom frames a plausible clinical strategy: for APOE4 carriers with elevated ApoB, a combination of low-dose statin plus ezetimibe may target both cardiovascular and brain health simultaneously. He notes that existing trial biobanks from ezetimibe studies could in principle be mined for pre- and post-treatment P-tau and amyloid-beta-40/42 data without needing a new trial.
Ezetimibe works in the gut and can't cross the blood-brain barrier — but its metabolite, ezetimibe glucuronide, can. Animal studies show it interferes with hexokinase and reduces brain protein glycosylation, producing anti-inflammatory effects. Neurologists already report anecdotal cognitive benefits in patients.
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
A study found that simply scheduling enjoyable activities was as effective as standard cognitive behavioral therapy for depression, leading to its own therapy called behavioral activation.
The 'worry time' technique — deferring all worries to a designated time of day — helps people realize they have more control over worry than they thought and reveals it is less useful than it feels.
A study found that participants told to try to stay awake while in bed fell asleep faster than participants told to try to sleep — illustrating the paradox of direct effort.
Spencer Greenberg reduced his severe social anxiety dramatically in roughly 6 months through a structured exposure therapy hierarchy, culminating in asking strangers for hugs.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.